|

Lymph Node Identification Using Magtrace and Magseed Before Chemotherapy

RECRUITINGSponsored by Vastra Gotaland Region
Actively Recruiting
SponsorVastra Gotaland Region
Started2025-09-01
Est. completion2027-12-31
Eligibility
Age18 Years – 85 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06104371

Summary

Magnetic tracer injected before preoperative chemotherapy in breast cancer patients for sentinel lymph node detection. Also, magnetic tracer in combination with magnetic clip for index node identification.

Eligibility

Age: 18 Years – 85 YearsHealthy volunteers accepted
Inclusion criteria:

* Patients 18 years of age or older.
* Patients with breast cancer planned to undergo NACT with

  * planned sentinel lymph node dissection (SLND), or
  * targeted axillary lymph node dissection (TAD), in conjunction with the
* breast surgery after NACT.

Exclusion Criteria:

* Intolerance / hypersensitivity to iron or dextran compounds or SPIO.
* Patients who are required to undergo MRI to evaluate tumour response.
* Pregnancy or breast feedin.g
* Patients with an iron overload disease.
* Patient deprived of liberty or under guardianship.
* Inability to understand given information and give informed consent or undergo study procedure

Conditions2

Breast CancerCancer

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.